The Role of Risk Factors in the Development of Atherosclerosis
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis in Critical Reviews in Clinical Laboratory Sciences
- Vol. 38 (5) , 401-440
- https://doi.org/10.1080/20014091084245
Abstract
Our understanding of risk factors for atherogenesis has changed significantly over the last decade. In addition to better grasp of the mechanism of action of the "classic" (causal) risk factors, a number of potentially important new factors has emerged. In this review we briefly summarize the evidence of the relation between atherosclerosis and the currently recognized causal risk factors, namely, age, smoking, LDL cholesterol, HDL cholesterol, hypertension, and diabetes. More emphasis has been put on description of the emerging entities such as atherogenic profile of plasma lipoproteins with discussion of LDL and HDL subclasses, Lp(a), homocysteine, and, last but not least, on the role of infection and inflammation in atherogenesis. Whenever possible, we tried to summarize the relevant lines of evidence such as epide-miological, pathological, genetic, and clinical trial data linking the specific factor with atherosclerosis.Keywords
This publication has 116 references indexed in Scilit:
- The seven countries study: 2,289 deaths in 15 yearsPublished by Elsevier ,2004
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cellsLife Sciences, 2000
- Low-Density Lipoprotein-Induced Expression of Interleukin-6, a Marker of Human Mesangial Cell Inflammation: Effects of Oxidation and Modulation by LovastatinBiochemical and Biophysical Research Communications, 2000
- Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarctionEuropean Heart Journal, 1999
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- The acute phase responseImmunology Today, 1994
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Changes in Plasma Lipids and Lipoproteins in Overweight Men during Weight Loss through Dieting as Compared with ExerciseNew England Journal of Medicine, 1988
- The Risk of Myocardial Infarction after Quitting Smoking in Men under 55 Years of AgeNew England Journal of Medicine, 1985